09Apr/13

Satellite Symposia on Defibrotide and Veno-Occlusive Disease at EBMT 39th … – GlobeNewswire (press release)

Satellite Symposia on Defibrotide and Veno-Occlusive Disease at EBMT 39th
GlobeNewswire (press release)
In, “VOD: a potentially life-threatening early complication of HSCT,” Dr. Sarah Marktel (Pediatric Immunohematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy) discussed the disease’s clinical presentation,

and more »

09Apr/13

Innovator's New Book Unveils Tips and Tricks To Avoid Corporate Antibodies … – San Francisco Chronicle

Innovator’s New Book Unveils Tips and Tricks To Avoid Corporate Antibodies
San Francisco Chronicle
Innovator’s New Book Unveils Tips and Tricks To Avoid Corporate Antibodies, Organ Rejection, and Death by PowerPoint. The Innovator’s Extinction, which rose to become the #1 download in Amazon’s management category this month, relates the

and more »

09Apr/13

EyeGate's EGP-437 Matches the Standard-of-Care's Response Rate in Phase III … – PipelineReview.com (press release)

EyeGate’s EGP-437 Matches the Standard-of-Care’s Response Rate in Phase III
PipelineReview.com (press release)
Our team has invested several years into developing this delivery platform and continues to advance our understanding of its versatility beyond the use of corticosteroids, such as EGP-437, including the delivery of proteins to the back of the eye
Study: Iontophoretic corticosteroid treatment matches standard-of-care Healio

all 2 news articles »